148 related articles for article (PubMed ID: 10576984)
1. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
Kotrlik J
Gastrointest Endosc; 1999 Nov; 50(5):728-9. PubMed ID: 10576984
[No Abstract] [Full Text] [Related]
2. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L
Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400
[TBL] [Abstract][Full Text] [Related]
3. The use of long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
Tenner SM; Van Dam J
Gastrointest Endosc; 1995 Nov; 42(5):497-8. PubMed ID: 8566651
[No Abstract] [Full Text] [Related]
4. Octreotide in the prevention of post-ERCP pancreatic injury.
Herszenyi L; Tulassay Z
Am J Gastroenterol; 2007 Jul; 102(7):1539-40. PubMed ID: 17593164
[No Abstract] [Full Text] [Related]
5. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
6. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis.
Andriulli A; Loperfido S
Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163
[No Abstract] [Full Text] [Related]
7. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
Foster E; Leung J
Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
[TBL] [Abstract][Full Text] [Related]
8. Can octreotide prevent post-ERCP pancreatitis?
Kaya E
Am J Gastroenterol; 2007 Jul; 102(7):1540-1; author reply 1541-2. PubMed ID: 17593165
[No Abstract] [Full Text] [Related]
9. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
[TBL] [Abstract][Full Text] [Related]
10. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
11. Complications of endoscopic sphincterotomy and their prevention.
Huibregtse K
N Engl J Med; 1996 Sep; 335(13):961-3. PubMed ID: 8782505
[No Abstract] [Full Text] [Related]
12. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
Manolakopoulos S; Avgerinos A; Vlachogiannakos J; Armonis A; Viazis N; Papadimitriou N; Mathou N; Stefanidis G; Rekoumis G; Vienna E; Tzourmakliotis D; Raptis SA
Gastrointest Endosc; 2002 Apr; 55(4):470-5. PubMed ID: 11923756
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-alpha and IL-6 after endoscopic retrograde cholangiopancreatography.
Kapetanos D; Christodoulou D; Chatzizisi O; Sigounas D; Vasiliou K; Stavropoulou E; Katodritou E; Kokozidis G; Kiriazis G; Kitis G; Tsianos E
Eur J Gastroenterol Hepatol; 2009 May; 21(5):529-33. PubMed ID: 19373973
[TBL] [Abstract][Full Text] [Related]
14. Octreotide and post-ERCP pancreatitis.
Kaya E
Gastrointest Endosc; 2007 Aug; 66(2):420-1; author reply 421-2. PubMed ID: 17643727
[No Abstract] [Full Text] [Related]
15. High dose of octreotide as a prophylaxis of post-ERCP pancreatitis.
Andriulli A
Gastrointest Endosc; 2007 Aug; 66(2):421; author reply 421-2. PubMed ID: 17643730
[No Abstract] [Full Text] [Related]
16. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography.
Balmadrid B; Kozarek R
Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966
[TBL] [Abstract][Full Text] [Related]
17. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
Kisli E; Baser M; Aydin M; Guler O
Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of post-ERCP acute pancreatitis with octreotide].
Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
Gostout CJ
Am J Gastroenterol; 1993 Dec; 88(12):2138-9. PubMed ID: 8249995
[No Abstract] [Full Text] [Related]
20. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
Stas KJ; Lamberts SW
Am J Gastroenterol; 1993 Sep; 88(9):1461-2. PubMed ID: 8362855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
